Summit Securities Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-1,000
Closed -$18K 345
2013
Q2
$18K Buy
+1,000
New +$18K 0.01% 222